Clinical Trial

Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General Anesthesia

Study acronym: INGRESS
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine if treatment of pre-induction hypertension with an intravenous short acting calcium channel antagonist will (1) reduce the magnitude and duration of blood pressure excursions outside of a pre-established normal range and (2) decrease the requirement for vasoactive medications during the period from induction of anesthesia until just prior to surgical incision.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-25.
Trial Details
NCT Number NCT06063772
Lead Sponsor University of California, San Diego
Conditions Hypertension
Enrollment 64 participants
Start Date 2025-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-11-08